Take Care of Your “Health-Lite” Claims

Mar 14, 2024 by Author: Annie Ugurlayan, Assistant Director, National Advertising Division, BBB National Programs

Now more than ever consumers are paying attention to their health and wellness and in the last year the Federal Trade Commission (FTC) has proven that they are paying attention too. Their focus is on advertisers touting the benefits and unique health-related features of their products.

Some advertisers believe they can avoid the scrutiny of regulators and the National Advertising Division (NAD) when making health-related claims by making their claim “softer.” An example would be trying to use ingredient claims instead, such as “Formulated with X” or adding that the product “helps” to treat a health-related condition.   

But context is key. If this claim is associated with health benefits, then advertisers must be mindful of the FTC’s Health Products Compliance Guidance, which was updated at the end of 2022 to replace the FTC’s 1998 Dietary Supplements. 

The substantiation bar is not lowered by changing the approach to the health-related claim. If you tout the presence of an ingredient in your product as providing a health benefit, consumers may understand that your product confers that benefit so you must have competent and reliable scientific evidence to support that implied takeaway.  

Similarly, if you qualify your claim to state that the product “helps to” or “may” confer a benefit, consumers understand the claim to mean that the product will provide some benefit, rather than understanding the qualifying language as a substantial disclaimer. 

Shortly after the updated Health Products guidance was released, the FTC put advertisers on notice, warning that claims about the health or safety benefits of a product must be truthful, not misleading, and most importantly substantiated with scientific evidence. 

When it comes to reliance on research, the guidance recommends that advertisers ensure that:

  • The research is both internally valid but also relevant to their specific product and to the specific advertised benefit. 
  • The research reflects the dosage and formulation of the advertised product as well as how well the outcomes tested in the study relate to the specific benefits advertised.
  • If there are significant discrepancies between research conditions and the real-life use being promoted, advertisers have evaluated whether it is appropriate to extrapolate from the research to the claimed effect.
  • The claims accurately reflect what the research shows.


Claims that don’t match the research results, no matter how sound that research is, are likely to be found as deceptive. The Health Guidance’s Example 23 is particularly instructive: 

“An advertiser conducts a literature search and finds several abstracts summarizing clinical studies about the association between a nutrient and the ability to perform better on memory tests. The advertiser relies on these summaries to support a claim that its supplement, which contains the same nutrient, aids memory. However, without looking carefully at the specifics of the study design, implementation, and results, there is no way for the advertiser to ascertain whether the research substantiates the product claims. (For example, did the research use a comparable formulation of the ingredient? Was the study adequately controlled? Did the study yield between-group results that are statistically significant?) Thus, the advertiser should carefully review the underlying science with the assistance of an expert before drafting advertising claims.”

These guiding principles inform health-related claims such as “our product lowers blood pressure” as well as “softer” claims. 


Takeaway Tips 

1. Quality, not quantity, of the research is what matters – multiple unreliable studies ≠ a reliable study.

2. When it comes to the science underlying ingredient claims, the product’s intended use and target population of your product are critical.

  • Studies on an elderly, diseased population are not a good fit for a product directed to a healthy general population.
  • Don’t forget about the dose, formulation, and method of administration: if the studied ingredients do not match the product, the study will be deemed unreliable to support product claims.


These important reminders can ensure that your claims pass muster before the FTC and NAD and provide useful information to consumers to make more informed purchasing decisions.  

Originally published by HBW Insight.

Suggested Articles


American Privacy Rights Act: A Primer for Business

Was it the recent series of natural phenomena that prompted Congress to move on a bipartisan, bicameral federal privacy bill? We can’t say with certainty, but we can outline for you what we believe to be, at first glance, the most compelling elements of the American Privacy Rights Act of 2024 (APRA).
Read more

Take Care of Your “Health-Lite” Claims

Some advertisers believe they can avoid scrutiny when making health-related claims by making their claim “softer.” But context is key. Health benefit claims must comply with the FTC’s Health Products Compliance Guidance. The substantiation bar is not lowered by changing the approach to the health-related claim.
Read more

Bullish but Cautionary: A Balanced Way to Approach the Impact of AI

Business and nonprofit leaders in the U.S. may not feel so weighty a responsibility in assessing the global impact of AI, but we must realize AI’s power to impact our organizations, our local economies, our sectors, and our nation.
Read more

New Rules of the Road Can Sustain US Leadership on Interoperable Digital Data Flows

President Biden closed February 2024 with an EO that signaled an important development for how the U.S. plans to position and guard itself from global adversaries, and speaks volumes about how the U.S. views the next-generation impacts of data flows on the digital economy and how our nation can be better equipped as a global leader. Read our takeaways and future considerations.
Read more